INT21349
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
LTB4 interacts with the high-affinity BLT1 receptor expressed by immune/inflammatory cells, thus exerting a powerful chemoattractant effect particularly on neutrophils, but also on CD8+ T-cells (Martin et al 1989; Goodarzi et al 2003). | |||||||||||||||
| |||||||||||||||
|
Evidence also indicates that 15-S-HETE may have anti-tumorigenic effects by antagonizing other LOX products, such as LTB4 and 12-S-HETE [28]. 15-HETE inhibits LTB4 production and reduces LTB4 binding to its receptors and thereby blocks cellular responses to LTB4. 15-HETE also blocks platelet-type 12-LOX activity and reduces 5-LOX activity in rat basophilic leukemia cells [28,32]. | |||||||||||||||
| |||||||||||||||
|
Fundic LTB4 and LTC4 generation was similar in ulcer patients and controls. | |||||||||||||||
| |||||||||||||||
|
The non-cysteinyl LT, LTB4, binds to the B leukotriene (BLT) receptor, which is responsible for recruitment and activation of leukocytes, in particular neutrophils (Yokomizo et al 1997; Devillier et al 1999a). | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.